DEA Confirms No Veterinary Phenylpropanolamine Tracking Requirements

Based on a request from two state veterinary medical associations, the AVMA sought, and received, confirmation that the Combat Methamphetamine Epidemic Act of 2005 (CMEA) does not apply to tracking of veterinary sales of phenylpropanolamine, a veterinary prescription drug. Concerns and questions originated from veterinarians who had received information from a continuing education-oriented presentation, which reportedly suggested that veterinarians were required to track their sales of phenylpropanolamine. Upon receipt of AVMA’s inquiry, the Drug Enforcement Administration (DEA) verified its 2006 rules implementing the CMEA, which indicate that the CMEA only applies to certain nonprescription drugs.

Although there are no federal DEA requirements for veterinarians to track their phenylpropanolamine sales, veterinarians should make certain to follow any state requirements on drug-sales tracking that might be in place (see links to state veterinary medical associations and state veterinary boards).

Comments are closed.